The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Stuart Jon Spechler

VA North Texas Healthcare System and the University of Texas Southwestern Medical Center


TX 75216



Name/email consistency: high



  • VA North Texas Healthcare System and the University of Texas Southwestern Medical Center, Dallas, TX 75216, USA. 2001 - 2010
  • Department of Medicine, Division of Gastroenterology, VA North Texas Healthcare System, 4500 South Lancaster Road, USA. 2009
  • Division of Gastroenterology, Dallas VA Medical Center, Dallas, TX 75216, USA. 2004 - 2007
  • Division of Gastroenterology (111B1), Department of Veterans Affairs Medical Center, 4500 S Lancaster Rd, Dallas, USA. 2001 - 2005
  • Department of Medicine, VA Medical Center, Dallas, Texas, USA. 2004
  • Dallas VA Medical Center, TX 75216, USA. 2002


  1. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Spechler, S.J., Fitzgerald, R.C., Prasad, G.A., Wang, K.K. Gastroenterology (2010) [Pubmed]
  2. Clinical trial: intragastric acid control in patients who have Barrett's oesophagus--comparison of once- and twice-daily regimens of esomeprazole and lansoprazole. Spechler, S.J., Barker, P.N., Silberg, D.G. Aliment. Pharmacol. Ther. (2009) [Pubmed]
  3. Endoscopic therapy in Barrett's esophagus: when and how?. Spechler, S.J., Davila, R. Surg. Oncol. Clin. N. Am. (2009) [Pubmed]
  4. Screening and surveillance for Barrett's esophagus-an unresolved dilemma. Spechler, S.J. Nature Clinical Practice. Gastroenterology & Hepatology (2007) [Pubmed]
  5. Barrett's esophagus: a molecular perspective. Spechler, S.J. Curr. Gastroenterol. Rep (2005) [Pubmed]
  6. Risk of community-acquired pneumonia after acid-suppressive drugs. Spechler, S.J. Nature Clinical Practice. Gastroenterology & Hepatology (2005) [Pubmed]
  7. Are we underestimating acid reflux?. Spechler, S.J. Gut (2004) [Pubmed]
  8. Review article: screening and surveillance of Barrett's oesophagus: what is a cost-effective framework?. Spechler, S.J., Barr, H. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  9. Intestinal metaplasia at the gastroesophageal junction. Spechler, S.J. Gastroenterology (2004) [Pubmed]
  10. Review article: what I do now to manage adenocarcinoma risk, and what I may be doing in 10 years' time. Spechler, S.J. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  11. What is the long-term effect of high-dose versus standard-dose omeprazole in patients with dyspepsia?. Spechler, S.J. Nature Clinical Practice. Gastroenterology & Hepatology (2004) [Pubmed]
  12. A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus. Spechler, S.J. JAMA (2003) [Pubmed]
  13. The natural history of dysplasia and cancer in esophagitis and Barrett esophagus. Spechler, S.J. J. Clin. Gastroenterol. (2003) [Pubmed]
  14. Clinical manifestations and esophageal complications of GERD. Spechler, S.J. Am. J. Med. Sci. (2003) [Pubmed]
  15. Medical or invasive therapy for GERD: an acidulous analysis. Spechler, S.J. Clin. Gastroenterol. Hepatol. (2003) [Pubmed]
  16. Esophageal complications of gastroesophageal reflux disease: presentation, diagnosis, management, and outcomes. Spechler, S.J. Clin. Cornerstone (2003) [Pubmed]
  17. Columnar-lined esophagus. Definitions. Spechler, S.J. Chest Surg. Clin. N. Am. (2002) [Pubmed]
  18. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Spechler, S.J., Jain, S.K., Tendler, D.A., Parker, R.A. Aliment. Pharmacol. Ther. (2002) [Pubmed]
  19. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. Spechler, S.J., Lee, E., Ahnen, D., Goyal, R.K., Hirano, I., Ramirez, F., Raufman, J.P., Sampliner, R., Schnell, T., Sontag, S., Vlahcevic, Z.R., Young, R., Williford, W. JAMA (2001) [Pubmed]
  20. Classification of oesophageal motility abnormalities. Spechler, S.J., Castell, D.O. Gut (2001) [Pubmed]
WikiGenes - Universities